Evaluation of the Hepatoprotective Effects of a Nutritional Supplement in Patients With Liver Disease Secondary to Chronic Hepatitis C Virus Infection (RESQUETI Study).

Recruiting

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

Mexico

Hospital Civil de Guadalajara Fray Antonio Alcalde, Guadalajara, Jalisco